Emergent Health Corp. Updates Shareholders
28 Fevereiro 2011 - 12:34PM
Emergent Health Corp. (Pink Sheets:EMGE) (the "Company") is pleased
to announce our securities have been approved to be traded by
market makers as of February 2011. This means our stock is once
again able to trade with "bids" and "asks" on the OTC Market,
formerly known as Pink Sheets. We are excited about this
development and hope it will renew confidence in shareholders that
the Company is one with a long term vision for success with ongoing
stock trading transparency intentions.
Our initial market maker is B.M.A. Securities (BMA). BMA is a
FINRA member full service brokerage firm. BMA is located in Rolling
Hill Estates, CA and offers a wide array of financial services.
These include: market making, institutional trading, investment
banking, advisory and consulting services.
We continue our efforts to increase both domestic and
international sales. Our Physician Formulated Vita-Stim product
promotes stem cell nutrition naturally. It was approved by the
Cambodia Ministry of Health for resale the last quarter of 2010.
Sales there, and in other parts of S.E. Asia, are in a
developmental stage.
The Company's unaudited revenues for 2010 exceeded those of
fiscal 2009 by almost 7% ($241,830 compared to $226,192). Pre-tax
profits appear to be similar in the $40,000.00 range despite added
expenses. Our comparable Balance Sheets for those years show
continued improved strength in assets primarily through prudent
cash management.
There is a video presentation of the Company and we invite you
to view:
http://video214.com/play/YkqFsktfzOuT5RrzvYFY6g/s/dark
Those interested in distribution of our products in the USA may
contact us below.
We wish to thank all of our shareholders for their patience and
understanding.
About Emergent Health Corp.
Emergent Health Corp., a diversified biotechnology firm, is
focused on the health and wellness industry. With
patented and patent pending nutritionally designed products,
Emergent believes it is positioning itself as a leader in the field
of Regenerative Medicine as defined by the National Institute of
Health.
Sign up for Free Newsletter Updates here:
http://emergenthealth.com
This press release contains certain "forward-looking"
statements, defined in the United States Private Securities
Litigation Reform Act of 1995, that involve a number of risks and
uncertainties. Statements, which are not historical facts, are
forward-looking statements. The company, through its management,
makes forward-looking public statements concerning its expected
future operations, performance and other developments. Such
forward-looking statements are estimates reflecting the company's
best judgment based upon current information and involve a number
of risks and uncertainties, and there can be no assurance that
other factors will not affect the accuracy of such forward-looking
statements. It is impossible to identify all such factors, factors
that could cause actual results to differ materially from those
estimated by the company.
This press release is provided for information purposes only and
is not intended to constitute an offer to sell or a solicitation of
an offer to buy securities.
CONTACT: Emergent Health Corp.
866-427-6143
Emergent Health (PK) (USOTC:EMGE)
Gráfico Histórico do Ativo
De Ago 2024 até Set 2024
Emergent Health (PK) (USOTC:EMGE)
Gráfico Histórico do Ativo
De Set 2023 até Set 2024